Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a trainee reporter for Medical Device Network, covering developments in the healthcare sector. Coming from a scientific and medical background, Robert has reported across various topics with expertise in neuroscience, genetics, and epidemiology. Previously, he worked on a freelance basis with New Scientist.
-
-
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer…
-
Atara’s T cell programmes hit with clinical hold after third-party site woes
Atara Therapeutics’ pipeline has hit another obstacle after the US Food and Drug Administration (FDA) halted clinical trials evaluating two…
-
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop…
-
Arrowhead’s plozasiran set for FDA review as Tryngolza challenge looms
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) for Arrowhead Pharmaceutical’s plozasiran in the…
-
FDA beats EMA to most approved new drugs in 2024
The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs…
-
InflaRx wins EU approval for Gohibic in Covid-19-induced ARDS
The European Commission (EC) has granted marketing authorisation under exceptional circumstances for InflaRx’s Gohibic (vilobelimab) for the treatment of SARS-CoV-2-induced…
-
WHO reports eight deaths from suspected Marburg outbreak in Tanzania
Eight people have likely died from an outbreak of Marburg virus disease (MVD) in a northwestern region of Tanzania, according…
-
Eisai and Biogen’s subcutaneous Leqembi set for FDA review
Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment Leqembi…
-
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
In moves that continue to strengthen its affiliation with the healthcare industry, NVIDIA has added three new companies to its…